Gene · 123
Papers3,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRPV1 regulates ApoE4-disrupted intracellular lipid homeostasis and decreases synaptic phagocytosis by microglia. | Exp Mol Med | 2023 | 36720919 | PubTator, text mining | PubMed |
| Optimization and Validation of a Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations. | Transl Vis Sci Technol | 2023 | 36716040 | PubTator, text mining | PubMed |
| Naturally forming benzoic acid orientates perilipin to facilitate glyceride-type polyunsaturated fatty acid degradation via fermentation behavior. | J Dairy Sci | 2023 | 36710193 | PubTator, text mining | PubMed |
| Comprehensive analysis regarding the prognostic significance of downregulated ferroptosis-related gene AKR1C2 in gastric cancer and its underlying roles in immune response. | PLoS One | 2023 | 36701414 | PubTator, text mining | PubMed |
| Hedgehog and Platelet-derived Growth Factor Signaling Intersect during Postnatal Lung Development. | Am J Respir Cell Mol Biol | 2023 | 36693140 | PubTator, text mining | PubMed |
| Pseudocoloboma-like maculopathy with biallelic RDH12 missense mutations. | J Med Genet | 2023 | 36690427 | PubTator, text mining | PubMed |
| Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review. | Int J Mol Sci | 2023 | 36674599 | PubTator, text mining | PubMed |
| Druggable Biomarkers Altered in Clear Cell Renal Cell Carcinoma: Strategy for the Development of Mechanism-Based Combination Therapy. | Int J Mol Sci | 2023 | 36674417 | PubTator, text mining | PubMed |
| PDZD8-deficient mice manifest behavioral abnormalities related to emotion, cognition, and adaptation due to dyslipidemia in the brain. | Mol Brain | 2023 | 36658656 | PubTator, text mining | PubMed |
| A novel homozygous TUB mutation associated with autosomal recessive retinitis pigmentosa in a consanguineous Chinese family. | BMC Med Genomics | 2023 | 36650547 | PubTator, text mining | PubMed |
| Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview. | Clin Transl Oncol | 2023 | 36650321 | PubTator, text mining | PubMed |
| Integrated multimodality microscope for accurate and efficient target-guided cryo-lamellae preparation. | Nat Methods | 2023 | 36646896 | PubTator, text mining | PubMed |
| A topographic atlas defines developmental origins of cell heterogeneity in the human embryonic lung. | Nat Cell Biol | 2023 | 36646791 | PubTator, text mining | PubMed |
| Simultaneous blockade of VEGF-B and IL-17A ameliorated diabetic kidney disease by reducing ectopic lipid deposition and alleviating inflammation response. | Cell Death Discov | 2023 | 36646672 | PubTator, text mining | PubMed |
| Metabolomics to identify fingerprints of carotid atherosclerosis in nonobese metabolic dysfunction-associated fatty liver disease. | J Transl Med | 2023 | 36624524 | PubTator, text mining | PubMed |
| Activation of β-Adrenoceptors Promotes Lipid Droplet Accumulation in MCF-7 Breast Cancer Cells via cAMP/PKA/EPAC Pathways. | Int J Mol Sci | 2023 | 36614209 | PubTator, text mining | PubMed |
| Si-Ni-San reduces lipid droplet deposition associated with decreased YAP1 in metabolic dysfunction-associated fatty liver disease. | J Ethnopharmacol | 2023 | 36608777 | PubTator, text mining | PubMed |
| Prognostic and clinicopathologic significance of PLIN2 in cancers: A systematic review with meta-analysis. | Int J Biol Markers | 2023 | 36604990 | PubTator, text mining | PubMed |
| Transcription factors: key regulatory targets of vascular smooth muscle cell in atherosclerosis. | Mol Med | 2023 | 36604627 | PubTator, text mining | PubMed |
| Tumor hypoxia: From basic knowledge to therapeutic implications. | Semin Cancer Biol | 2023 | 36603793 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/123/papers?page=32